This Week In Medicine®: Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: Findings of the DISRUPT CAD III Trial 2-Year Follow-up
Listen to Podcast Disclosures: TBD
Clinical Trial Results
Search
Dr. C. Michael Gibson Presents: Secondary Prevention with Aspirin – Learn about the Latest FDA Approved Aspirin Formulation View
Disclosures: Consultant to PLx Pharma Inc.
Aspirin Therapy in 2022: New Horizons
A CME-Jointly Accredited Program This activity is supported by an independent educational grant from PLx Pharma Inc.
Aspirin in 2022: A New Aspirin for a New Chapter
Dr. Neha J. Pagidipati, Dr. Jacqueline E. Tamis-Holland, Dr. Dominick J. Angiolillo and Dr. C. Michael Gibson Discuss: Aspirin in […]